Search research articles
Contact Us
Filters
Showing results (71-80 of 278) with videos related to
Page
of 28
Sort By:
International Journal of Antimicrobial Agents
|
May 18, 2020
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values
Mariana Castanheira, Timothy B Doyle, Cory Hubler, et al.
Open Forum Infectious Diseases
|
February 13, 2023
Trends of β-Lactamase Occurrence Among <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type
Mariana Castanheira, John H Kimbrough, Sean DeVries, et al.
Journal of Clinical Microbiology
|
June 24, 2025
Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in <i>Streptococcus pneumoniae</i> clinical isolates from the United States according to CLSI guidelines (2019-2021)
Rodrigo E Mendes, Jessica V Pierce, Kelly Wright, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
Rodrigo E Mendes, Ronald N Jones, Leah N Woosley, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2017
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016
Helio S Sader, Mariana Castanheira, Dee Shortridge, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 2017
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015
Mariana Castanheira, Leonard R Duncan, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 2026
In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United States
Joshua M Maher, Rodrigo E Mendes, Mark Jones, et al.
Open Forum Infectious Diseases
|
March 2, 2023
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Open Forum Infectious Diseases
|
September 4, 2024
High Rates of Nonsusceptibility to Common Oral Antibiotics in <i>Streptococcus pneumoniae</i> Clinical Isolates From the United States (2019-2021)
Lalitagauri M Deshpande, Michael D Huband, Sarah Charbon, et al.
The Journal of Antimicrobial Chemotherapy
|
February 17, 2009
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
Ronald N Jones, Gary J Moet, Helio S Sader, et al.
Page
of 28
Search research articles
Search
Showing results (71-80 of 278) with videos related to
Sort By:
Page
of 28
International Journal of Antimicrobial Agents
|
May 18, 2020
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values
Mariana Castanheira, Timothy B Doyle, Cory Hubler, et al.
Open Forum Infectious Diseases
|
February 13, 2023
Trends of β-Lactamase Occurrence Among <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type
Mariana Castanheira, John H Kimbrough, Sean DeVries, et al.
Journal of Clinical Microbiology
|
June 24, 2025
Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in <i>Streptococcus pneumoniae</i> clinical isolates from the United States according to CLSI guidelines (2019-2021)
Rodrigo E Mendes, Jessica V Pierce, Kelly Wright, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
Rodrigo E Mendes, Ronald N Jones, Leah N Woosley, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2017
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016
Helio S Sader, Mariana Castanheira, Dee Shortridge, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 2017
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015
Mariana Castanheira, Leonard R Duncan, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 2026
In vitro activity of ceftobiprole against Gram-positive clinical bacterial isolates causing skin and skin structure infections in the United States
Joshua M Maher, Rodrigo E Mendes, Mark Jones, et al.
Open Forum Infectious Diseases
|
March 2, 2023
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Open Forum Infectious Diseases
|
September 4, 2024
High Rates of Nonsusceptibility to Common Oral Antibiotics in <i>Streptococcus pneumoniae</i> Clinical Isolates From the United States (2019-2021)
Lalitagauri M Deshpande, Michael D Huband, Sarah Charbon, et al.
The Journal of Antimicrobial Chemotherapy
|
February 17, 2009
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
Ronald N Jones, Gary J Moet, Helio S Sader, et al.
Page
of 28